ARIS
BIIB icon

Advanced Research Investment Solutions’s Biogen BIIB Stock Holding History

Advanced Research Investment Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$1K – 36
2022
Q3 		$1K Hold
5
– – ﹤0.01% 156
2022
Q2 		$1K Hold
5
– – ﹤0.01% 128
2022
Q1 		$1K Sell
5
-20
-80% -$4.35K ﹤0.01% 184
2021
Q4 		$6K Hold
25
– – ﹤0.01% 164
2021
Q3 		$7.08K Hold
25
– – ﹤0.01% 120
2021
Q2 		$9K Hold
25
– – 0.01% 54
2021
Q1 		$7K Hold
25
– – 0.01% 50
2020
Q4 		$6K Buy
+25
New +$6.45K 0.01% 45

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Advanced Research Investment Solutions's BIIB Position: Q4 2022 in Review

Advanced Research Investment Solutions sold out of Biogen (BIIB) in Q4 2022, closing a stake of 5 shares — an estimated $1K sold.

Advanced Research Investment Solutions first reported a position in BIIB in Q4 2020 and held it in 8 quarters. The position peaked at $9K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Advanced Research Investment Solutions reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Advanced Research Investment Solutions sold 5 Biogen shares in Q4 2022, an estimated $1K.
  • Advanced Research Investment Solutions first reported a position in Biogen in Q4 2020 and held it in 8 quarters.
  • Advanced Research Investment Solutions's Biogen position peaked at $9K in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Advanced Research Investment Solutions's 13F filing for Q4 2022, filed 10 Feb 2023.